Skip to content

Tranexamic Acid for the Latarjet Procedure.

A Randomised, Prospective Evaluation on the Effectiveness of Tranexamic Acid in Reducing Postoperative Swelling and Haematoma Formation After the Latarjet Procedure.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03458468
Enrollment
100
Registered
2018-03-08
Start date
2018-03-01
Completion date
2019-03-01
Last updated
2019-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Shoulder Instability

Keywords

tranexamic acid, anterior shoulder instability, latarjet, hematoma

Brief summary

The investigators propose a double-blinded randomized study evaluating the effectiveness of tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet procedure. The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via intra-articular injection at the time of surgery in patients undergoing the Latarjet procedure for shoulder instability.

Interventions

DRUGTranexamic Acid

1g Tranexamic acid prior to skin incision

DRUGSaline

Equivalent volume of saline prior to skin incision

Sponsors

Sports Surgery Clinic, Santry, Dublin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Double-blinded randomized

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Anterior shoulder instability, warranting the Latarjet procedure

Exclusion criteria

* Patients with known risk factors for hyper-coagulable state * Patients under 16 * Patients unable to give consent to partake in the trial

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumptionPostoperative day-1
Hematoma FormationPostoperative day-1Patients hematoma formation will be evaluated using the Pauzenberger criteria (Grade 1-4)
Visual Analogue ScalePostoperative day-1
Total Drain outputPostoperative day-1The total drain output of blood post-operatively

Secondary

MeasureTime frame
Wound complicationsPostoperative week-2
Haematoma FormationPostoperative week-2
Total complicationsPostoperative month-4

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026